KPMA vows to stem predatory pricing in hospital biddings

Published: 2013-02-22 07:00:00

Updated: 2013-02-22 07:00:00

The Korea Pharmaceutical Manufacturers Association (KPMA) on Tuesday vowed to stem the long-standing drug dumpling practice in hospital bidding sector and set the market order straight.

To this end, the KPMA sent a circular letter to the Korea Medical Association, Seoul City Hospital Associat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK